ArticleOncotarget2019

Safety and effectiveness of FOLFOXIRI plus molecular target drug therapy for metastatic colorectal cancer: A multicenter retrospective study.

Takatsugu Ogata et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.